Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Do women >or=50 years of age need as much screening as women <50 years after they have had negative screening results?

Armaroli P, Gallo F, Bellomi A, Ciatto S, Consonni D, Davi D, Giorgi-Rossi P, Iossa A, Mancini E, Naldoni C, Polla E, Ronco G, Serafini M, Vergini V, Zanier L, Zappa M, Segnan N.

Br J Cancer. 2008 Jul 22;99(2):239-44. doi: 10.1038/sj.bjc.6604455. Epub 2008 Jul 1.

2.

Risk of CIN2 in women with a pap test without endocervical cells vs. those with a negative pap test with endocervical cells: a cohort study with 4.5 years of follow-up.

Giorgi Rossi P, Baiocchi D, Ciatto S; Endocervical Cell Italian Working Group of Cervical Cancer Screening Group..

Acta Cytol. 2010 May-Jun;54(3):265-71.

PMID:
20518409
3.

Risk of cervical cancer associated with extending the interval between cervical-cancer screenings.

Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, Lee NC, Gildengorin G, Myers ER, Washington AE.

N Engl J Med. 2003 Oct 16;349(16):1501-9.

4.
5.

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A.

J Natl Cancer Inst. 2009 Dec 2;101(23):1612-23. doi: 10.1093/jnci/djp367. Epub 2009 Nov 9.

PMID:
19903804
6.

Primary high-risk HPV screening for cervical cancer in post-menopausal women.

Gyllensten U, Gustavsson I, Lindell M, Wilander E.

Gynecol Oncol. 2012 May;125(2):343-5. doi: 10.1016/j.ygyno.2012.01.036. Epub 2012 Jan 28.

PMID:
22293044
7.

Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.

Salmerón J, Lazcano-Ponce E, Lorincz A, Hernández M, Hernández P, Leyva A, Uribe M, Manzanares H, Antunez A, Carmona E, Ronnett BM, Sherman ME, Bishai D, Ferris D, Flores Y, Yunes E, Shah KV.

Cancer Causes Control. 2003 Aug;14(6):505-12.

PMID:
12948281
8.

Frequency of cervical smear abnormalities within 3 years of normal cytology.

Sawaya GF, Kerlikowske K, Lee NC, Gildengorin G, Washington AE.

Obstet Gynecol. 2000 Aug;96(2):219-23.

PMID:
10908766
11.

HPV testing in primary screening of older women.

Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T, Soutter P.

Br J Cancer. 1999 Oct;81(3):554-8.

12.

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.

J Natl Cancer Inst. 2003 Jan 1;95(1):46-52.

PMID:
12509400
13.

Cervical cancer screening. Organised screening to avoid unnecessary conisation.

[No authors listed]

Prescrire Int. 2010 Aug;19(108):172-7, 179. Review.

PMID:
20939454
14.

Self-sampling of vaginal fluid and high-risk human papillomavirus testing in women aged 50 years or older not attending Papanicolaou smear screening.

Lindell M, Sanner K, Wikström I, Wilander E.

BJOG. 2012 Jan;119(2):245-8. doi: 10.1111/j.1471-0528.2011.03147.x. Epub 2011 Oct 21.

15.
16.

Human papillomavirus (HPV) infections as risk factors for cytological and histological abnormalities in baseline PAP smear-negative women followed-up for 2 years in the LAMS study.

Gontijo RC, Derchain SF, Roteli-Martins C, Bragança JF, Sarian LO, Morais SS, Maeda MY, Longatto-Filho A, Syrjänen KJ.

Eur J Obstet Gynecol Reprod Biol. 2007 Aug;133(2):239-46. Epub 2006 Jun 30.

PMID:
16814450
17.

Performance indicators of organized cervical screening in Romagna (Italy).

Bucchi L, Falcini F, Schincaglia P, Desiderio F, Bondi A, Farneti M, Casadei Giunchi D, Serafini M, Canuti D, Caprara L, Sabbadini F, Monari F, Sassoli P.

Eur J Cancer Prev. 2003 Jun;12(3):223-8.

PMID:
12771561
19.

Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: Characteristics of the responders.

Gök M, Heideman DA, van Kemenade FJ, de Vries AL, Berkhof J, Rozendaal L, Beliën JA, Overbeek L, Babović M, Snijders PJ, Meijer CJ.

Eur J Cancer. 2012 Aug;48(12):1799-808. doi: 10.1016/j.ejca.2011.11.022. Epub 2011 Dec 13.

Supplemental Content

Support Center